# Deutsche Bank Aktiengesellschaft: overview DB · NYSE · CIK 1159508 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/db.md) · [Financials](/companies/db/financials.md) · [Filings](/companies/db/filings.md) · [Insiders](/companies/db/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [25.5](/filings/0001159508-24-000021.md) | [27.1](/filings/0001159508-25-000020.md) | [31.2](/filings/0001159508-26-000017.md) | [31.5](/filings/0001159508-26-000017.md) | [31.4](/filings/0001159508-26-000017.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [9.6%](/filings/0001159508-24-000021.md) | [20.0%](/filings/0001159508-24-000021.md) | [20.3%](/filings/0001159508-24-000021.md) | not reported | not reported | | Diluted EPS | $ per share | [0.97](/filings/0001159508-24-000021.md) | [2.32](/filings/0001159508-24-000021.md) | [2.77](/filings/0001159508-24-000021.md) | not reported | not reported | | Free cash flow | $bn | [(3.5)](/filings/0001159508-24-000021.md) | [(2.5)](/filings/0001159508-24-000021.md) | [5.2](/filings/0001159508-24-000021.md) | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/db/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Arlington Trust Co LLC](/funds/1997685.md) | 2026-06-30 | $2.3m | 18,000 | | Unchanged | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.5m | 11,887 | | New +11,887 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $634.9k | 4,878 | | Reduced −157,638 | | [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $494.6k | 2,938 | | New +2,938 | | [Scientech Research LLC](/funds/2011556.md) | 2026-06-30 | $278.7k | 2,141 | | Reduced −401 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $256.8k | 1,973 | | New +1,973 | | [FIDUCIARY FINANCIAL ADVISORS](/funds/2116119.md) | 2026-06-30 | $182.5k | 1,402 | | New +1,402 | | [IFP Advisors, Inc](/funds/1641866.md) | 2026-06-30 | $107.4k | 825 | | New +825 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $83.1k | 13,043 | | Unchanged | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $3.3k | 25 | | Unchanged | ## Recent filings [All 9,166 filings](/companies/db/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 06:04 ET | [6-K](/filings/0001159508-26-000044.md) | Report of a foreign private issuer, period 2026-09-30 | 0001159508-26-000044 | | 2026-10-01 | 10:33 ET | [6-K](/filings/0001159508-26-000040.md) | Report of a foreign private issuer, period 2026-09-30 | 0001159508-26-000040 | | 2026-09-25 | 16:29 ET | [6-K](/filings/0001839882-26-047373.md) | Report of a foreign private issuer, period 2026-09-25 | 0001839882-26-047373 | | 2026-07-29 | 06:04 ET | [6-K](/filings/0001159508-26-000038.md) | Report of a foreign private issuer, period 2026-06-30 | 0001159508-26-000038 | | 2026-07-01 | 09:50 ET | [6-K](/filings/0001159508-26-000033.md) | Report of a foreign private issuer, period 2026-06-30 | 0001159508-26-000033 | | 2026-05-29 | 09:56 ET | [6-K](/filings/0001159508-26-000031.md) | Report of a foreign private issuer, period 2026-05-29 | 0001159508-26-000031 | | 2026-04-29 | 07:19 ET | [6-K](/filings/0001159508-26-000029.md) | Report of a foreign private issuer, period 2026-04-29 | 0001159508-26-000029 | | 2026-04-08 | 10:34 ET | [6-K](/filings/0001159508-26-000025.md) | Report of a foreign private issuer, period 2026-04-08 | 0001159508-26-000025 | | 2026-04-01 | 09:22 ET | [6-K](/filings/0001159508-26-000023.md) | Report of a foreign private issuer, period 2026-03-31 | 0001159508-26-000023 | | 2026-03-12 | 06:16 ET | [6-K](/filings/0001159508-26-000021.md) | Report of a foreign private issuer, period 2026-03-12 | 0001159508-26-000021 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001159508-26-000017.md), filed Mar 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1159508 - Tickers: DB, ADZCF, DEENF, DGP, DGZ, DZZ, OLOXF - Exchange: NYSE - SIC code: 6022 State Commercial Banks - State of incorporation: not reported - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:49 ET. No prices; not investment advice.